全文获取类型
收费全文 | 25613篇 |
免费 | 2750篇 |
国内免费 | 974篇 |
专业分类
耳鼻咽喉 | 565篇 |
儿科学 | 177篇 |
妇产科学 | 535篇 |
基础医学 | 2339篇 |
口腔科学 | 466篇 |
临床医学 | 1878篇 |
内科学 | 2030篇 |
皮肤病学 | 286篇 |
神经病学 | 290篇 |
特种医学 | 1486篇 |
外国民族医学 | 38篇 |
外科学 | 4638篇 |
综合类 | 3766篇 |
预防医学 | 389篇 |
眼科学 | 189篇 |
药学 | 1051篇 |
5篇 | |
中国医学 | 344篇 |
肿瘤学 | 8865篇 |
出版年
2024年 | 18篇 |
2023年 | 385篇 |
2022年 | 591篇 |
2021年 | 1021篇 |
2020年 | 944篇 |
2019年 | 772篇 |
2018年 | 705篇 |
2017年 | 921篇 |
2016年 | 968篇 |
2015年 | 1242篇 |
2014年 | 1670篇 |
2013年 | 1488篇 |
2012年 | 1563篇 |
2011年 | 1664篇 |
2010年 | 1454篇 |
2009年 | 1398篇 |
2008年 | 1490篇 |
2007年 | 1437篇 |
2006年 | 1378篇 |
2005年 | 1308篇 |
2004年 | 1078篇 |
2003年 | 983篇 |
2002年 | 823篇 |
2001年 | 665篇 |
2000年 | 624篇 |
1999年 | 508篇 |
1998年 | 435篇 |
1997年 | 326篇 |
1996年 | 222篇 |
1995年 | 233篇 |
1994年 | 192篇 |
1993年 | 129篇 |
1992年 | 118篇 |
1991年 | 82篇 |
1990年 | 73篇 |
1989年 | 63篇 |
1988年 | 60篇 |
1987年 | 50篇 |
1986年 | 36篇 |
1985年 | 41篇 |
1984年 | 39篇 |
1983年 | 26篇 |
1982年 | 23篇 |
1981年 | 30篇 |
1980年 | 25篇 |
1979年 | 15篇 |
1978年 | 11篇 |
1977年 | 5篇 |
1974年 | 2篇 |
1972年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
对于结直肠癌患者,术后复发转移是导致其死亡的主要原因。大量研究显示中医药在结直肠癌复发转移的预防方面有着良好疗效。本文从临床研究入手,针对疾病不同分期,从结直肠癌术后辨证分型的临床研究及中医药预防结直肠癌复发转移的临床试验研究两方面展开论述,发现问题并给出未来临床研究方向的建议。本文旨在为结直肠癌术后复发转移中医药预防的临床研究提供思路和方法,把控好中医药在结直肠癌全过程防治中关键环节,更好地继承发扬中医药在“治未病”中的独特优势。 相似文献
2.
目的:挖掘并筛选与甲状腺乳头状癌(papillary thyroid carcinoma,PTC)淋巴结转移相关的突变基因及其潜在的机制。方法:从TCGA数据库获得377例PTC患者的测序数据及完整的临床资料,并分为淋巴结转移组(LM,n=212)与无淋巴结转移组(NLM,n=165)。利用R语言(v3.6.2)对转移组特有的突变基因进行富集分析。采用String在线软件绘制蛋白互作网络,Cytoscape软件筛选网络中的核心基因。在UALCAN网站上验证基因表达量与淋巴结转移之间的关系。利用荧光实时定量PCR测定候选基因在细胞系中mRNA的表达量。结果:一共筛选出1197个仅在LM组发生突变的基因,它们主要富集在黏着连接、细胞黏附分子(cell adhesion molecules,CAMs)通路。CAMs通路的核心基因ITGB1与VCAN的表达量与淋巴结转移相关。与正常甲状腺细胞系相比,VCAN基因在PTC细胞系TPC-1和B-CPAP中mRNA的表达量较高,尤其是B-CPAP细胞系。结论:CAMs通路可能是PTC淋巴结转移相关机制之一,其中VCAN基因可能是潜在的分子标志物。 相似文献
3.
4.
5.
《Cirugía espa?ola》2023,101(2):116-122
IntroductionMetastasis is remaining one of the major problems in cancer treatment. Like many other malignancies, urogenital tumors originating from kidney, prostate, testes, and bladder tend to metastasize to the lungs.The aim of this retrospective study is to evaluate the operative results and prognosis of pulmonary metastasectomy in patients with primary urogenital tumors.MethodsThis study was approved by the local ethical committee. We retrospectively analyzed the surgical and oncological results of patients who underwent lung resections for urogenital cancer metastases in our department between 2002 and 2018. Demographic data and clinicopathological features were extracted from the medical records. Survival outcomes according to cancer subtypes and early postoperative results of VATS and thoracotomy were analyzed.Results22 out of 126 patients referred for pulmonary metastasectomy to our department had metastases from urogenital tumors. These patients consisted of 17 males and five females. Their metastasis originated from renal cell carcinoma (RCC; n = 9), bladder tumor (n = 7), testis tumors (n = 4), and prostate cancer (n = 2). There was no intraoperative complication. Postoperative complications were seen in 2 patients.ConclusionsAlthough pulmonary metastasectomy in various types of tumors is well known and documented, the data is limited for metastases of urogenital cancers in the literature. Despite the limitations of this study, we aim to document our promising results of pulmonary metastasectomy in patients with primary urogenital tumors and wanted to emphasize the role of minimally invasive approaches. 相似文献
6.
7.
8.
目的探究槐耳颗粒对肝癌根治术后复发转移的影响。方法114例行肝癌根治术患者,按治疗方法不同分为对照组(54例)和观察组(60例)。对照组行常规治疗,观察组行常规+槐耳颗粒治疗。对比两组生存及肿瘤复发转移情况、血管内皮细胞生长因子(VEGF)、血清甲胎蛋白(AFP)、总胆红素(TB)、丙氨酸转氨酶(ALT)、生活质量改善情况。结果观察组存活率90.00%高于对照组的75.93%,复发转移率8.33%低于对照组的25.93%,差异有统计学意义(P<0.05)。治疗后,观察组VEGF(413.54±21.05)pg/ml、AFP(356.32±25.36)μg/L均低于对照组的(486.53±20.43)pg/ml、(415.69±21.32)μg/L,差异有统计学意义(P<0.05)。治疗后,观察组TB(18.63±1.34)μmol/L、ALT(52.78±5.32)U/L低于对照组的(21.66±1.25)μmol/L、(56.23±5.63)U/L,差异有统计学意义(P<0.05)。观察组患者生活质量改善情况优于对照组,差异有统计学意义(P<0.05)。结论槐耳颗粒在防治肝癌术后肿瘤复发转移方面具有明显效果,推荐使用。 相似文献
9.
《European journal of surgical oncology》2022,48(7):1650-1655
PurposeTo examine the annual hospital volume of surgery in relation to survival in colorectal cancer. Previous studies on hospital volume and survival following colorectal cancer surgery are conflicting.MethodsAll 49 032 patients who underwent resection for colorectal cancer in 1987–2016 in Finland were included, with complete follow-up until December 31, 2019. Primary outcome was 5-year mortality. Cox regression provided hazard ratios (HR) with 95% confidence intervals (CI) for quartiles of annual hospital volume for colorectal surgery, adjusted for calendar period, age, sex, comorbidity, stage, tumor location and oncological therapy. Additionally, colon and rectal cancer surgery were assessed separately. Sensitivity analysis of patients with confirmed curative intent was conducted.ResultsCompared to highest quartile (≥108 resections annually), lowest hospital volume (≤37 resections annually) was associated with slightly increased 5-year all-cause mortality (adjusted HR 1.07, 95% CI 1.02–1.12). A pre-planned subgroup-analysis suggested a slightly improved 5-year survival in high-volume institutions for rectal cancer, but not colon cancer surgery. Sensitivity analysis including only those operated with confirmed curative intent suggested no differences between hospital volume groups in colorectal, colon or rectal cancer for 5-year all-cause mortality.ConclusionHigher hospital volume is associated with slightly improved all-cause 5-year mortality in colorectal cancer surgery, but this effect may be limited to rectal cancer surgery only. Volume-outcome relationship in rectal cancer surgery should be investigated further using large datasets. These results do not support centralization of colon cancer surgery based on hospital volume only. 相似文献
10.
《European journal of surgical oncology》2019,45(12):2392-2397
IntroductionEarly recurrence (ER) is defined as development of loco-regional peritoneal disease within 12-month of the initial CRS/PIC. Our aims were to identify overall survival (OS), recurrence-free survival (RFS) and independent prognostic factors associated with ER in PM of appendiceal neoplasm.Materials and methodsA prospectively-maintained database for patients with appendiceal neoplasm undergoing cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC) from year 1996–2018 was retrospectively analysed.Results208 female and 185 male patients were identified. With a median follow-up of 40-month, 40.2% of the patients developed ER. The median OS for ER was 24 months compared to late (LR) at 64 months. Median OS was not reached in non-recurrence (NR). 5-year survival for ER was less favourable compared to LR and NR (19.3%vs54.6%vs94%). No patients in ER group survived beyond 10-year. Independent negative predictors associated with ER on multivariate analysis were male patient (p = 0.013), blood transfusion of >8 units (p = 0.013), elevated preoperative CEA levels (>5 ng/ml; p = 0.002) and hard intraoperative tumour consistency (p < 0.001). Protective factor was a combination of CC1, hard tumour consistency and use of EPIC (p = 0.039). Independent prognostic factors that predicted recurrence of appendiceal PM were PCI >20 (p = 0.049), non-use of EPIC (p = 0.012), hard tumour consistency (p = 0.004) and use of previous chemotherapy (p = 0.023).ConclusionER following CRS and PIC of appendiceal PM is associated with reduced survival outcomes. Our data alludes to the importance of optimising the risk factors in order to delay loco-regional recurrence and improve long-term survival of these patients. 相似文献